What are biogenerics?
Biogenerics are generic versions of currently marketed biologics. Biologics are large-protein molecules derived from genetically modified cell lines. (This is in contrast to small-molecule pharmaceuticals, which are made from chemical substances.) Some of these drugs can cost more than $100,000 per year per patient. With a growing number of patents for branded biologics expiring, biogenerics represent a large, emerging market. “Generic” biologics are often referred to as biosimilars in Europe and biogenerics in the United States. They can also be referred to as similar biologics, generic biologics, follow-on biologics or follow-on proteins.
